EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Revisiting endothelial tropism of SARS-CoV-2 using a cell-specific hACE2 mouse model

Sahine Lameire iD, Nincy Debeuf, Julie Deckers, Caroline De Wolf, Manon Vanheerswynghels, Wendy Toussaint, Lize De Vlieger, Lien Van Hoecke, Arnout Bruggeman, Sieglinde De Cae, Bert Schepens, Stijn Vanhee und 1 weitere

Microbiology Spectrum · 2026

DOI: 10.1128/spectrum.01311-26 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, 2026. Verfasst von Sahine Lameire und 12 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Immunoregulation and Mucosal Immunology, VIB Center for Inflammation Research, Ghent, Belgium. Hauptthemen laut MEDLINE: Angiotensin-Converting Enzyme 2, Viral Tropism, SARS-CoV-2, Endothelial Cells. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Severe COVID-19 is frequently associated with vascular complications, raising ongoing debate about whether SARS-CoV-2 can directly infect endothelial cells and thereby contribute to disease pathogenesis. Although endothelial cells express angiotensin-converting enzyme 2 (ACE2), the in vivo relevance of endothelial-restricted viral tropism remains unclear. To directly assess the consequences of endothelial-restricted SARS-CoV-2 tropism in vivo , we generated a transgenic mouse model expressing human ACE2 under control of the endothelial-specific Cdh5 promoter ( Cdh5 -hACE2). Despite confirmed pulmonary endothelial expression and protein presence of hACE2, SARS-CoV-2 infection of Cdh5 -hACE2 mice did not induce clinical illness, detectable viral replication, immune cell influx in the lung, or histopathological abnormalities in the lung or brain. These findings indicate that endothelial-restricted SARS-CoV-2 tropism alone is insufficient to drive productive infection and clinical disease in vivo , suggesting that endothelial involvement in COVID-19 likely arises in the context of broader cellular infection or systemic host responses rather than from primary endothelial infection. IMPORTANCE Although SARS-CoV-2 primarily infects the upper and lower airways, COVID-19 was quickly recognized as a multi-organ disease, in which vascular complications are a recurring feature. This has raised the possibility that direct infection of endothelial cells contributes to disease pathogenesis. However, whether vascular injury arises from productive endothelial infection or instead represents a secondary consequence of systemic inflammation remains unresolved. To directly disentangle these possibilities and define the in vivo consequences of endothelial-restricted viral tropism, we generated a transgenic mouse model expressing human ACE2 under the control of the endothelial-specific Cdh5 promoter ( Cdh5 -hACE2).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Angiotensin-Converting Enzyme 2Viral TropismSARS-CoV-2Endothelial CellsCOVID-19Peptidyl-Dipeptidase AAnimalsHumansMice, TransgenicMiceDisease Models, AnimalLungCadherin 5Antigens, CDCadherinsVirus ReplicationBrainPromoter Regions, Genetic

Stichwörter der Autor:innen

coronavirusendothelial dysfunctionimmunologymouse modelviral tropism

Substanzen

Angiotensin-Converting Enzyme 2ACE2 protein, humanAce2 protein, mouseCadherin 5Antigens, CDCadherinsPeptidyl-Dipeptidase A

Autor:innen und Institutionen

  • Laboratory of Immunoregulation and Mucosal Immunology, VIB Center for Inflammation Research, Ghent, Belgium.
  • Department of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium.
  • Barriers in Inflammation, VIB Center for Inflammation Research, Ghent, Belgium.
  • Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium.
  • Department of Neurology, University Hospital Ghent, Ghent, Belgium.
  • VIB UGent Center for Medical Biotechnology, Ghent, Belgium.

ORCID-Profile: Sahine Lameire, Bart N Lambrecht

Zitieren

APA

Lameire, S., Debeuf, N., Deckers, J., De Wolf, C., Vanheerswynghels, M., Toussaint, W., De Vlieger, L., Van Hoecke, L., Bruggeman, A., De Cae, S., Schepens, B., Vanhee, S., & Lambrecht, B. N. (2026). Revisiting endothelial tropism of SARS-CoV-2 using a cell-specific hACE2 mouse model. Microbiology Spectrum. https://doi.org/10.1128/spectrum.01311-26

Vancouver

Lameire S, Debeuf N, Deckers J, De Wolf C, Vanheerswynghels M, Toussaint W, et al. Revisiting endothelial tropism of SARS-CoV-2 using a cell-specific hACE2 mouse model. Microbiology Spectrum. 2026. doi:10.1128/spectrum.01311-26

BibTeX
@article{Lameire2026,
  author = {Lameire, Sahine and Debeuf, Nincy and Deckers, Julie and De Wolf, Caroline and Vanheerswynghels, Manon and Toussaint, Wendy and De Vlieger, Lize and Van Hoecke, Lien and Bruggeman, Arnout and De Cae, Sieglinde and Schepens, Bert and Vanhee, Stijn and Lambrecht, Bart N},
  title = {Revisiting endothelial tropism of SARS-CoV-2 using a cell-specific hACE2 mouse model},
  journal = {Microbiology Spectrum},
  year = {2026},
  doi = {10.1128/spectrum.01311-26}
}
Kostenlos starten →